Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
The Manual for Well known rough terrain Vehicles - 2Chicago reports first rabies-positive dog in 61 years. What we know.
- 35 Worldwide Road Food varieties You Should Attempt
- 4New heart disease calculator predicts 30-year risk for young adults
- 5Figure out how to Arrange a Fair Settlement with the Assistance of a Fender bender Legal counselor
- Black Friday Paramount+ deal: Save 50% and stream these buzzy Taylor Sheridan shows
- The Universe of Impeccable Pearls: A Manual for Valuable Gems
- Ocean side Locations for a Family Excursion
- Australian State Triggers Emergency Powers Amid Fuel Crisis
- I traveled to 13 countries in 2025. This small island nation surprised me the most.
- Wisconsin archaeologists identify 16 ancient canoes in a prehistoric lake 'parking lot'
- Factbox-China's crewed lunar programme eyes astronaut landing by 2030
- Building Tough Connections: Individual Bits of knowledge on Association
- Which Breakfast Enraptures Your Taste Buds? Vote
